Scopus BioPharma Inc. – NASDAQ:SCPS
Scopus BioPharma stock price today
Scopus BioPharma stock price monthly change
Scopus BioPharma stock price quarterly change
Scopus BioPharma stock price yearly change
Scopus BioPharma key metrics
Market Cap | 12.62K |
Enterprise value | N/A |
P/E | -0.06 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | -0.19 |
PEG ratio | N/A |
EPS | -0.31 |
Revenue | N/A |
EBITDA | -9.34M |
Income | -8.69M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeScopus BioPharma stock price history
Scopus BioPharma stock forecast
Scopus BioPharma financial statements
| Sep 2022 | 0 | -1.89M | |
|---|---|---|---|
| Dec 2022 | 0 | -1.73M | |
| Mar 2023 | 0 | -2.44M | |
| Jun 2023 | 0 | -2.61M |
| Sep 2022 | 415676 | 5.91M | 1424.1% |
|---|---|---|---|
| Dec 2022 | 392265 | 7.45M | 1900.36% |
| Mar 2023 | 1603327 | 9.31M | 580.87% |
| Jun 2023 | 497554 | 11.00M | 2211.24% |
| Sep 2022 | -851.65K | 0 | 0 |
|---|---|---|---|
| Dec 2022 | -421.90K | -1.55M | 241.94K |
| Mar 2023 | -759.85K | 0 | 2.01M |
| Jun 2023 | -1.00M | 0 | -44.68K |
Scopus BioPharma alternative data
| Aug 2023 | 13 |
|---|---|
| Sep 2023 | 13 |
| Oct 2023 | 13 |
| Nov 2023 | 13 |
| Dec 2023 | 13 |
| Jan 2024 | 13 |
| Feb 2024 | 13 |
| Mar 2024 | 13 |
| Apr 2024 | 13 |
| May 2024 | 13 |
| Jun 2024 | 13 |
| Jul 2024 | 13 |
Scopus BioPharma other data
| Period | Buy | Sel |
|---|---|---|
| Feb 2021 | 12530 | 0 |
| Jul 2021 | 4200 | 0 |
| Aug 2021 | 7950 | 0 |
-
What's the price of Scopus BioPharma stock today?
One share of Scopus BioPharma stock can currently be purchased for approximately $0.1.
-
When is Scopus BioPharma's next earnings date?
Unfortunately, Scopus BioPharma's (SCPS) next earnings date is currently unknown.
-
Does Scopus BioPharma pay dividends?
No, Scopus BioPharma does not pay dividends.
-
How much money does Scopus BioPharma make?
Scopus BioPharma has a market capitalization of 12.62K.
-
What is Scopus BioPharma's stock symbol?
Scopus BioPharma Inc. is traded on the NASDAQ under the ticker symbol "SCPS".
-
What is Scopus BioPharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Scopus BioPharma?
Shares of Scopus BioPharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Scopus BioPharma have?
As Jul 2024, Scopus BioPharma employs 13 workers.
-
When Scopus BioPharma went public?
Scopus BioPharma Inc. is publicly traded company for more then 4 years since IPO on 16 Dec 2020.
-
What is Scopus BioPharma's official website?
The official website for Scopus BioPharma is scopusbiopharma.com.
-
Where are Scopus BioPharma's headquarters?
Scopus BioPharma is headquartered at 420 Lexington Avenue, New York, NY.
-
How can i contact Scopus BioPharma?
Scopus BioPharma's mailing address is 420 Lexington Avenue, New York, NY and company can be reached via phone at +212 4792513.
Scopus BioPharma company profile:
Scopus BioPharma Inc.
scopusbiopharma.comNASDAQ
13
Biotechnology
Healthcare
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.
New York, NY 10170
CIK: 0001772028
ISIN: US8091711015
CUSIP: 809171101
